About ALSF

Study IDs Potential Treatment For Children with Relapsed Leukemia

 » View all news titles
 » View titles this week
» View titles this month

Columbia University Medical Center Newsroom


Most children with acute lymphoblastic leukemia (ALL) can be cured, but the prognosis is dismal for about 20 percent of patients who relapse after treatment.

Now a new study from researchers at Columbia University’s Herbert Irving Comprehensive Cancer Center has found that a mutation that leads to relapse in many ALL patients also causes a weakness that could be exploited to kill the cancer cells in patients experiencing relapse.

>>Read more